Literature DB >> 26841146

Assessing the Prevalence of Latent Tuberculosis among Health Care Providers in Zagazig City, Egypt Using Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test.

Rehab H El-Sokkary1, Ashwak M Abu-Taleb1, Omnia S El-Seifi2, Haidy E Zidan3, Eman M Mortada2, Dalia El-Hossary1, Salama E Farag4.   

Abstract

AIM: Early detection of latent tuberculosis infection (LTBI) will prevent development of active TB among health care providers. The aim of the study was to assess the prevalence of LTBI among health care providers and compare the QuantiFERON-TB Gold In-Tube Test (QFT-GIT) and Tuberculin skin test in efforts to detect LTBI and to investigate possible associated risk factors of infection.
METHODS: A cross sectional study was carried out during the period of 6 months in the Chest Hospital in Zagazig city and the Nephrology Unit at Zagazig University Hospitals in 132 randomly selected health care providers who were examined for LTBI by QFT-GIT and Tuberculin skin test and for the associated risk factors as well.
RESULTS: The prevalence of LTBI identified by QFT-GIT and by Tuberculin skin test was 28.8% and 59.1%, respectively. Poor agreement was observed between the two tests (kappa=0.10). Working more than 10 years, being nurse, diabetic and smoker were risk factors significantly associated with LTBI (p<0.05).
CONCLUSIONS: QFT-GIT is considered a useful tool in detecting LTBI cases, especially in a country where BCG vaccination is a national policy (as in Egypt). Duration of work, profession, diabetes and smoking are the risk factors for LTBI. Active surveillance and infection control measures are recommended to reduce the risk of LTBI. Copyright© by the National Institute of Public Health, Prague 2015.

Entities:  

Keywords:  QuantiFERON; Tuberculin skin test; health care providers; prevalence; tuberculosis

Mesh:

Year:  2015        PMID: 26841146     DOI: 10.21101/cejph.a4101

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  7 in total

1.  The Association Between Diabetes Mellitus and the Risk of Latent Tuberculosis Infection: A Systematic Review and Meta-Analysis.

Authors:  Qiao Liu; Wenxin Yan; Runqing Liu; Ershu Bo; Jue Liu; Min Liu
Journal:  Front Med (Lausanne)       Date:  2022-04-25

2.  Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.

Authors:  Tan N Doan; Damon P Eisen; Morgan T Rose; Andrew Slack; Grace Stearnes; Emma S McBryde
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

3.  Prevalence and risk factors of latent tuberculosis among Korean healthcare workers using whole-blood interferon-γ release assay.

Authors:  Jeong Hwa Yeon; Hye Seong; Ho Hur; Yoonseon Park; Young Ah Kim; Yoon Soo Park; Chang Hoon Han; Sun Min Lee; Jeong Hun Seo; Jung Gu Kang
Journal:  Sci Rep       Date:  2018-07-04       Impact factor: 4.379

4.  Screening for Latent Tuberculosis among Healthcare Workers in an Egyptian Hospital Using Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test.

Authors:  Manal Mohamed Anwar; Doaa Mabrouk Ahmed; Heba Reda Elareed; Radwa Ahmed-Rabea Abdel-Latif; Mostafa Saleh Sheemy; Nesreen Mostafa Kamel; Maha Fathy Mohamed
Journal:  Indian J Occup Environ Med       Date:  2019-12-16

5.  Risk of Occupational Latent Tuberculosis Infection among Health Personnel Measured by Interferon-Gamma Release Assays in Low Incidence Countries-A Systematic Review and Meta-Analysis.

Authors:  Claudia Peters; Agnessa Kozak; Albert Nienhaus; Anja Schablon
Journal:  Int J Environ Res Public Health       Date:  2020-01-16       Impact factor: 3.390

Review 6.  Prevalence of Latent Tuberculosis Infection in the Middle East and North Africa: A Systematic Review.

Authors:  Mazin Barry
Journal:  Pulm Med       Date:  2021-01-28

Review 7.  Exposure to Occupational Hazards among Health Care Workers in Low- and Middle-Income Countries: A Scoping Review.

Authors:  Rajni Rai; Sonia El-Zaemey; Nidup Dorji; Bir Doj Rai; Lin Fritschi
Journal:  Int J Environ Res Public Health       Date:  2021-03-05       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.